Statement of Chair Lina M. Khan In the Matter of Exxon Mobil Corporation
Date
Matter Number
241 0004
By
Lina M. Khan, Former Chair and Commissioner
Related Releases
Join us at the FTC!
Displaying 41 - 60 of 3904
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Welsh, Carson, Anderson & Stowe
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Dissenting Statement of Commissioner Melissa Holyoak Joined by Commissioner Andrew N. Ferguson In the Matter of ExxonMobil/Pioneer Resources
Date
Matter Number
241 0004
By
Melissa Holyoak, Commissioner;
Andrew N. Ferguson, Chairman
Related Releases
Chair Khan Letter to Rep. Fitzgerald Regarding Antitrust Litigation Costs
Date
By
Lina M. Khan, Former Chair and Commissioner
Dissenting Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Surveillance Pricing 6(b) Staff Research Summaries
Date
Matter Number
P246202
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
AI-Related Programmatic Advances at the FTC (June 2021 - January 2025)
Date
By
Stephanie Nguyen, Former Chief Technologist
Related Releases
Chair Khan Letter to Sen. Van Hollen Regarding Antitrust Litigation Costs
Date
By
Lina M. Khan, Former Chair and Commissioner
Statement of Chair Lina M. Khan and Commissioner Alvaro M. Bedoya In the Matter of Non-Alcoholic Beverages Price Discrimination Investigation
Date
By
Lina M. Khan, Former Chair and Commissioner;
Alvaro Bedoya, Former Commissioner
Related Releases
Concurring and Dissenting Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the FTC Staff Report on AI Partnerships & Investments 6(b) Study
Date
Matter Number
P246201
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Related Releases
Chair Khan Letter to Sen. Lee Regarding Antitrust Litigation Costs
Date
By
Lina M. Khan, Former Chair and Commissioner
File
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak In the Matter of US Anesthesia Partners/Guardian Anesthesia
Date
Matter Number
201 0031
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
Date
Matter Number
241 0005
By
Lina M. Khan, Former Chair and Commissioner
File
Concurring and Dissenting Statement of Commissioner Melissa Holyoak Joined by Commissioner Andrew N. Ferguson In Matter of AI Partnerships and Investments 6(b) Study
Date
Matter Number
P246201
By
Melissa Holyoak, Commissioner;
Andrew N. Ferguson, Chairman
Related Releases
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Welsh, Carson, Anderson & Stowe
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Dissenting Statement of Commissioner Melissa Holyoak Joined by Commissioner Andrew N. Ferguson In the Matter of ExxonMobil/Pioneer Resources
Date
Matter Number
241 0004
By
Melissa Holyoak, Commissioner;
Andrew N. Ferguson, Chairman
Related Releases
Chair Khan Letter to Rep. Joyce Regarding Antitrust Litigation Costs
Date
By
Lina M. Khan, Former Chair and Commissioner
File
Dissenting Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Surveillance Pricing 6(b) Staff Research Summaries
Date
Matter Number
P246202
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
State by State Constituent Support for FTC Noncompete Rule
Date
By
Lina M. Khan, Former Chair and Commissioner
File
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Welsh, Carson, Anderson & Stowe
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Displaying 41 - 60 of 3904